Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 467(3): 484-90, 2015 Nov 20.
Article in English | MEDLINE | ID: mdl-26456657

ABSTRACT

The ATP-gated P2X4 and P2X7 receptors are cation channels, co-expressed in excitable and non-excitable cells and play important roles in pain, bone development, cytokine release and cell death. Although these receptors interact the interacting domains are unknown and the functional consequences of this interaction remain unclear. Here we show by co-immunoprecipitation that P2X4 interacts with the C-terminus of P2X7 and by fluorescence resonance energy transfer experiments that this receptor-receptor interaction is driven by ATP. Furthermore, disrupting the ATP-driven interaction by knocking-out P2X4R provoked an attenuation of P2X7-induced cell death, dye uptake and IL-1ß release in macrophages. Thus, P2X7 interacts with P2X4 via its C-terminus and disrupting the P2X7/P2X4 interaction hinders physiological responses in immune cells.


Subject(s)
Macrophages/metabolism , Receptors, Purinergic P2X4/metabolism , Receptors, Purinergic P2X7/metabolism , Animals , Fluorescence Resonance Energy Transfer , Fluorescent Dyes , HEK293 Cells , Humans , Mice , Mice, Inbred C57BL , Mice, Knockout
2.
Biochim Biophys Acta ; 1852(1): 120-30, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25445541

ABSTRACT

Glioma cells release cytokines to stimulate inflammation that facilitates cell proliferation. Here, we show that Lipopolysaccharide (LPS) treatment could induce glioma cells to proliferate and this process was dependent on nucleotide receptor activation as well as interleukin-8 (IL-8/CXCL8) secretion. We observed that extracellular nucleotides controlled IL-8/CXCL8 and monocyte chemoattractant protein 1 (MCP-1/CCL2) release by U251MG and U87MG human glioma cell lines via P2X7 and P2Y6 receptor activation. The LPS-induced release of these cytokines was also modulated by purinergic receptor activation since IL-8 and MCP-1 release was decreased by the nucleotide scavenger apyrase as well as by the pharmacological P2Y6 receptor antagonists suramin and MRS2578. In agreement with these observations, the knockdown of P2Y6 expression decreased LPS-induced IL-8 release as well as the spontaneous release of IL-8 and MCP-1, suggesting an endogenous basal release of nucleotides. Moreover, high millimolar concentrations of ATP increased IL-8 and MCP-1 release by the glioma cells stimulated with suboptimal LPS concentration which were blocked by P2X7 and P2Y6 antagonists. Altogether, these data suggest that extracellular nucleotides control glioma growth via P2 receptor-dependent IL-8 and MCP-1 secretions.


Subject(s)
Brain Neoplasms/metabolism , Cell Proliferation , Chemokine CCL2/metabolism , Glioma/metabolism , Interleukin-8/metabolism , Receptors, Purinergic/physiology , Base Sequence , Brain Neoplasms/pathology , Cell Line, Tumor , DNA Primers , Glioma/pathology , Humans , Polymerase Chain Reaction , Receptors, Purinergic/genetics , Receptors, Purinergic/metabolism , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL